Riskpilot← Back to searchSign inGet full accessMedbase Group Oy
OYActiveY-tunnus 3256878-4Yliopistonkatu 15-B16Other information service activities · NACE 6392Est. 2021— employees
Revenue 2024
EUR 392M
+4% vs 2023
EBITDA margin
0.5%
-99% vs 2023
Equity ratio
30.9%
Financial strength
Net profit 2024
EUR 270K
-50% vs 2023
| Revenue | EUR 392M | +4% |
| EBITDA | EUR 2M | -99% |
| Net profit | EUR 270K | -50% |
| Total assets | EUR 3,4B | +10073% |
| Equity | EUR 1B | +10065% |
| Employees | — | — |
Legal name
Medbase Group Oy
Y-tunnus number
3256878-4
Legal form
Osakeyhtiö
NACE code
6392 · Other information service activities
Founded
23. joulukuuta 2021
Share capital
EUR 0
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Toimitusjohtaja yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on kaikki laillinen liiketoiminta.
Address
Yliopistonkatu 15-B16
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 3 757 | 378 257 | 392 035 |
| Staff expenses | −381 | −60 958 | −60 516 |
| EBITDA | 2 044 | 162 204 | 1 958 |
| Depreciation & amort. | −2 | −7 314 | −29 234 |
| EBIT | 2 042 | 154 890 | 110 167 |
| Net financials | −1 119 | −1 276 | −1 239 |
| Profit before tax | 923 | 21 083 | 410 |
| Tax | 307 | 205 | 140 |
| Net profit | 616 | 540 | 270 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 31 828 | 33 199 | 3 377 345 |
| Equity | 9 237 | 10 277 | 1 044 656 |
| Long-term debt | 20 274 | 19 510 | 21 127 |
| Short-term debt | 2 318 | 2 765 | 1 510 |
| Total debt | 22 591 | 22 275 | 22 637 |
EBITDA margin
0.5%
This company
15.8%
Market median
-97% vs market
20222024
Equity ratio
30.9%
This company
38.2%
Market median
+19% vs market
20222024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20222024
Net profit margin
0.1%
This company
8.1%
Market median
-99% vs market
20222024
Asset turnover
0.12×
This company
1.12×
Market median
-89% vs market
20222024
Debt / equity
2.23×
This company
0.62×
Market median
-260% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
MH Deputy Member | Deputy Member | 2025 |
SK Confidential Clerk | Confidential Clerk | 2025 |
AK Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (3) | ||
PJ Deputy Member | Deputy Member | 2022 – 2025 |
JV | Audit | 2022 – 2023 |
KP Chief Executive Officer | Chief Executive Officer | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairperson | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Holdbase Oy
Medbase Group Oy Board members of Medbase Group Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Max Håkan Emanuel Enhörning Admarker | Deputy Member | 0 companies |
| Philip John Michael Kaustinen | Deputy Member | 0 companies |
| Juha Veikko Aulis Hilmola | Audit | 0 companies |
| Kari Petri Laine | Chief Executive Officer | 0 companies |
| Simo Kalevi Pietilä | Confidential Clerk | 0 companies |
| Atte Kristian Auranen | Chief Executive Officer | 0 companies |
| Kari Lappalainen | Chairperson | 0 companies |
| Panu Kimmo Juhani Vuorela | Board of Directors | 0 companies |
| Katrin Wiemann | Board of Directors | 0 companies |
| Juha Antti Tuominen | Board of Directors | 0 companies |
| Ville Samuel Koskenvuo | Board of Directors | 0 companies |